Delisted

$0.001

Want access to our research and new buy ideas?

Take a free 15 day trial - no credit card required.

Start your free trial now

General Information

Alcyone Resources Limited
MYX
http://www.maynepharma.com
Pharmaceuticals
1,017
1,542

Current Price Data+

Current Price $0.001
Open $0.000
High $0.000
Low $0.000
Last Close $0.001
Volume 0
Price Movement - ( No change )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

Company Overview

Business Description

Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA.

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2019 F 74.48 4.93 -1.20% 12.88 0.00 0.00% 100.0%
2018 F 75.39 4.99 -19.20% 12.73 0.00 0.00% 100.0%
2017 A 90.20 6.18 10.60% 24.91 0.00 0.00% 100.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2017 A 2018 F 2019 F 2017 A 2018 F 2019 F 2017 A 2018 F 2019 F
Mayne Pharma Group (MYX) $975M 0.0476 -0.1624 0.1721 9.6358 11.5036 9.8145 0.00% 0.00% 0.00%
Starpharma (SPL) $495M 0.0000 0.0000 3.9923 0.0000 102.6923 20.5701 0.00% 0.00% 0.00%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.45 10.82 0.76 0.00
Market 1.15 16.80 1.55 1.81
Sector 0.80 11.50 3.61 1.75

Directors

Name Position Start Date
Mr Scott Anthony Richards Chief Executive Officer, Managing Director 13 Feb 2012
Mr Roger Campbell Corbett Non-Executive Chairman 17 Nov 2010
Mr Bruce L Mathieson Non-Executive Director 16 Feb 2007
Mr Ian Frank Scholes Non-Executive Director 17 Oct 2007
Ms Nancy Dolan Non-Executive Director 21 Sep 2016
Hon Ron Best Non-Executive Director 26 Jul 2006
Mr William Phillip Hodges Non-Executive Director 15 Nov 2012
Professor Bruce Gregory Robinson Non-Executive Director 26 Aug 2014

Management

Name Position
Nick Freeman Chief Financial Officer,Company Secretary
Mark Cansdale Chief Financial Officer,Company Secretary

Substantial Shareholders

Holding Name
0 (0%) Not Disclosed in Annual Report

Calendar of Events

Date Event
18 October 2018 Report (Annual)
24 August 2018 Report (Prelim)
23 February 2018 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.